Benjamin A. Rellinger, Ph.D. is a senior patent agent with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Rellinger provides legal and technological advice in support of validity and patentability analyses and has prosecuted numerous applications from initial art search through appeal and issuance. His expertise includes medical devices and implants, wearable devices, medical imaging and diagnostics, magnetic resonance imaging, flow cytometry and cell sorting, molecular imaging, rehabilitative and assistive devices and robotics, electrowetting actuators, electrophysiology, neuroscience, neuroprosthetics, brain-computer interfaces/brain-machine interfaces (BCI / BMI), electromyography (EMG), electrocardiography (ECG/EKG), deep brain stimulation (DBS), retinal and cochlear prostheses, machine learning, and image processing.
Dr. Rellinger has drafted or been involved in the prosecution of over a hundred patents in the U.S., as well as in other jurisdictions. He has experience in all phases of patent prosecution, including initial patent harvest, prior art searching, drafting of claims and of full applications, prosecution through to issuance including a number of issuances achieved via after-final pilot programs and appeal, and developing strategy for filing of continuing applications.
Prior to joining MBHB, Dr. Rellinger performed both basic and applied research in biomedical engineering, rehabilitation, and neuroscience. Dr. Rellinger engaged in applied research into invasive and non-invasive brain-computer interfaces and deep brain stimulation for the treatment of movement disorders. Dr. Rellinger also conducted experimental research into natural motor planning and control. Such experiments provided long-duration, high-quality electrophysiological signals across a variety of behaviors and following training in novel motor tasks. Dr. Rellinger also has experience in embedded device design and development.